Sergio Raposeiras-Roubin

Sergio Raposeiras-Roubín (Santiago de Compostela, November 26, 1983) holds a Bachelor's and Doctorate degree in Medicine and is a specialist in Cardiology. He currently works at Álvaro Cunqueiro Hospital in Vigo. He is a Professor of Medicine at the University of Santiago de Compostela and an External Researcher at the Spanish National Center for Cardiovascular Research (CNIC). He currently serves as the President-Elect of Clinical Cardiology at the Spanish Society of Cardiology and is Editor-in-Chief of REC:CardioClinics, a journal of the Spanish Journal of Cardiology. He received his clinical training at the University Clinical Hospital of Santiago de Compostela, Montefiore Hospital in New York (advanced heart failure), and the Royal Brompton Hospital in London (congenital heart disease). In 2013, he was awarded the National Prize for Best Medical Resident in Spain. He has completed an official Master's degree in Health Sciences Research (Complutense and Autónoma Universities of Madrid, and UNED), as well as three additional Master's degrees: in General Cardiology, Cardiovascular Imaging Techniques (both from the Spanish Society of Cardiology and Miguel Hernández University), and Healthcare Management (Nebrija University). He also holds a postgraduate diploma in Health Sciences Statistics from the Autonomous University of Barcelona. Dr. Raposeiras Roubín has had a significant impact on clinical cardiology. His research is cited an average of three times per day over the past three years, and he holds an H-index of 41. He has presented more than 300 communications at national and international conferences and has published over 250 indexed articles (33% as first author), with an average impact factor above 4. He is also the author of one book and has contributed chapters to 23 additional books. He is actively involved in multiple clinical trials, having served as principal investigator for the DapaTAVI trial (published as first author in The New England Journal of Medicine) and the BempedACS trial. He is also a member of the Executive Committee of the REBOOT trial. Additionally, he coordinates two international registries on acute coronary syndrome (BleeMACS and RENAMI). Among various distinctions, he has received the Research Award from the American College of Cardiology, the National Pfizer Research Award, and the Research Prize from the Royal Academy of Medicine. From May 2013 to January 2016, he worked at the University Clinical Hospital of Santiago de Compostela. Since February 2016, he has been part of the clinical cardiology team at Álvaro Cunqueiro Hospital, where he also served as Resident Tutor and Clinical Research Coordinator from 2016 to 2023. He was an Associate Professor of Health Sciences at the University of Vigo from 2022 to 2024, and has been a teaching collaborator at the University of Santiago de Compostela since 2013. In 2025, he was appointed Professor of Medicine at the same university. He is also a faculty member of several Master's programs (such as Heart Failure and Diabetes, coordinated by the Spanish Society of Cardiology), and a regular lecturer at training events held by “La Casa del Corazón.” Dr. Raposeiras Roubín serves as Associate Editor of BMC Cardiovascular Disorders and Editor-in-Chief of REC:CardioClinics. He has been an invited speaker at national cardiology congresses of the Spanish Society of Cardiology, the Italian Society of Cardiology, and the American College of Cardiology (Florida Chapter), and has delivered a MasterClass at the University of Michigan. He has lectured internationally in countries such as the United States, the Netherlands, Italy, Costa Rica, Panama, and Ecuador. He is a scientific committee member of CardioGroup (an international cardiovascular clinical research collaboration project).